295
Views
28
CrossRef citations to date
0
Altmetric
Review

Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century

, , , , &
Pages 1477-1486 | Published online: 09 Jan 2014

References

  • Trotter C, Samuelsson S, Perrocheau A et al. Ascertainment of meningococcal disease in Europe. Eurosurveillance10(12), 247–250 (2005).
  • Connolly M, Noah N. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993–1996. Epidemiol. Infect.122(1), 41–49 (1999).
  • Booy R, Habibi P, Nadel S et al. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch. Dis. Child85(5), 386–390 (2001).
  • Goldacre MJ, Roberts SE, Yeates D. Case fatality rates for meningococcal disease in an English population, 1963–1998: database study. BMJ327(7415), 596–597 (2003).
  • Thorburn K, Baines P, Thomson A, Hart CA. Mortality in severe meningococcal disease. Arch. Dis. Child85(5), 382–385 (2001).
  • European Centre for Disease Prevention and Control. Annual Epidemiological Report on Communicable Diseases in Europe. CDC, Stockholm, Sweden (2010).
  • Cohn AC, MacNeil JR, Harrison LH et al. Changes in Neisseria meningitidis Disease Epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin. Infect. Dis.50(2), 184–191 (2010).
  • Jensen ES, Schonheyder HC, Lind I, Berthelsen L, Norgard B, Sorensen HT. Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-year population-based historical follow-up study in a Danish county. J. Med. Microbiol.52(2), 173–179 (2003).
  • Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine27(Suppl. 2), B51–B63 (2009).
  • Teyssou R, Muros-Le Rouzic E. Meningitis epidemics in Africa: a brief overview. Vaccine25(Suppl. 1), A3–A7 (2007).
  • Greenwood B. Editorial: 100 years of epidemic meningitis in West Africa; has anything changed? Trop. Med. Int. Health11(6), 773–780 (2006).
  • WHO. Control of epidemic meningococcal disease. WHO Practical Guidelines (2nd Edition). WHO, Geneva, Switzerland (1998).
  • Caugant DA. Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease. Infect. Genet. Evol.8(5), 558–565 (2008).
  • Rameix-Welti MA, Zarantonelli ML, Giorgini D et al. Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules. Infect. Immun.77(9), 3588–3595 (2009).
  • Leimkugel J, Racloz V, Jacintho da Silva L, Pluschke G. Global review of meningococcal disease. A shifting etiology. J. Bacteriol Res.1(1), 006–018 (2009).
  • Boisier P, Nicolas P, Djibo S et al. Meningococcal meningitis: unprecedented incidence of serogroup X related cases in 2006 in Niger. Clin. Infect. Dis.44(5), 657–663 (2007).
  • Maiden MC, Bygraves JA, Feil E et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl Acad. Sci. USA95(6), 3140–3145 (1998).
  • Stollenwerk N, Maiden MC, Jansen VA. Diversity in pathogenicity can cause outbreaks of meningococcal disease. Proc. Natl Acad. Sci. USA101(27), 10229–10234 (2004).
  • Buckee CO, Jolley KA, Recker M et al. Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis. Proc. Natl Acad. Sci. USA105(39), 15082–15087 (2008).
  • Swartley JS, Marfin AA, Edupuganti S et al. Capsule switching of Neisseria meningitidis. Proc. Natl Acad. Sci. USA.94(1), 271–276 (1997).
  • Harrison LH, Shutt KA, Schmink SE et al. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre meningococcal conjugate vaccine United States, 2000-2005. J. Infect. Dis.201(8), 1208–1224 (2010).
  • Alcala B, Arreaza L, Salcedo C, Uria MJ, De La Fuente L, Vazquez JA. Capsule switching among C:2b:P1.2,5 meningococcal epidemic strains after mass immunization campaign, Spain. Emerg. Infect. Dis.8(12), 1512–1514 (2002).
  • Peltola H. Meningococcal disease: still with us. Rev. Infect. Dis.5(1), 71–91 (1983).
  • Kuzemenska P, Kriz B. Epidemiology of meningococcal disease in central and eastern Europe. In: Evolution of Meningococcal Disease. Vedros NA (Ed.). CRC Press Inc., Boca Raton, FL, USA, 103–137 (1987).
  • Tan LKK, Carlone GM, Borrow R. Advances in the development of vaccines against Neisseria meningitidis. N. Engl. J. Med.362(16), 1511–1520 (2010).
  • Centre for Disease Prevention and Control. Annual epidemiological report on communicable diseases in Europe. Centre for Disease Prevention and Control, Stockholm, Sweden (2009).
  • Abbott JD, Jones DM, Painter MJ, Young SEJ. The epidemiology of meningococcal infections in England and Wales, 1912–1983. J. Infect.11(3), 241–257 (1985).
  • Achtman M, van der EA, Zhu P et al. Molecular epidemiology of serogroup A meningitis in Moscow, 1969 to 1997. Emerg. Infect. Dis.7(3), 420–427 (2001).
  • World Health Organization. Weekly Epidemiological Record Year 20.39 (1945).
  • Mateo S, Cano R, Garcia C. Changing epidemiology of meningococcal disease in Spain 1989–1997. Eurosurveillance2(10), 71–74 (1997).
  • Hubert B, Goulet V, Riou J. Surveillance of meningococcal disease in France, 1990–1997. Eurosurveillance2(10), 78–79 (1997).
  • Stroffolini T, Congiu ME, Occhionero M, Mastrantonio P. Meningococcal disease in Italy. J. Infect.19(1), 69–74 (1989).
  • Fijen CAP, Kuijper EJ, Te Bulte MT, Daha MR, Dankert J. Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin. Infect. Dis.28(1), 98–105 (1999).
  • De Marie S, Poolman JT, Hoeijmakers JHJ. Meningococcal disease in The Netherlands, 1959–1981: the occurrence of serogroups and serotypes 2a and 2b of Neisseria meningitidis. J. Infect.12(2), 133–143 (1986).
  • De Maeyer S, Seba JM, Reginster G. Epidemiology of meningococcal meningitis in Belgium. J. Infect.3(Suppl. 1), 63–70 (1981).
  • Kriz P. Surveillance of invasive meningococcal disease in the Czech Republic. Eurosurveillance9(11), 37–39 (2004).
  • Fallon R. Meningococcal infections in Scotland, in meningococcal infection (edited by B. I. Duerden). J. Med. Microbiol.26, 161–187 (1988).
  • Peltola H, Jonsdottir K, Lystad A. Meningococcal disease in Scandinavia. BMJ284(6329), 1618–1621 (1982).
  • Poolman JT, Lind I, Jonsdottir K, Froholm LO, Jones DM, Zanen HC. Meningococcal serotypes and serogroup B disease in north-west Europe. Lancet2(8506), 555–558 (1986).
  • Jones D. Epidemiology of meningococcal infection in England and Wales, in meningococcal infection (edited by B. I. Duerden). J. Med. Microbiol.26, 161–187 (1988).
  • Scholten RJ, Bijmer H, Poolman JT et al. Meningococcal disease in The Netherlands, 1958–1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin. Infect. Dis.16(2), 237–246 (1993).
  • Titone L, Dones P, Salsa L, Schimmenti MG, Furnari ML, Romano A. Results from the center for meningococcal disease in Sicily (1985–1992). Med. J. Infect. Parasit Dis.9(2), 87–89 (1994).
  • Fallon RJ, Brown WM, Lore W. Meningococcal infections in Scotland 1972–1982. J. Hyg. (Lond.)93(2), 167–180 (1984).
  • Grahlow WD, Ocklitz HW, Mochmann H. Meningococcal infections in the German Democratic Republic, 1971–1984. Infection14(6), 286–288 (1986).
  • Koroleva IS, Platonov AE, Van der Ende A, Kuijper E, Dankert J. Characteristics of pathogenic Neisseria meningitidis in Moscow: prevalence of ‘non-European’ strains. Clin. Microbiol. Infect.4(3), 123–128 (1998).
  • Makela PH, Peltola H, Kayhty H et al. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J. Infect. Dis.136(Suppl.), S43–S50 (1977).
  • Hjetland R, Caugant DA, Hofstad T, Froholm LO, Selander RK. Serogroup A Neisseria meningitidis of clone III-1 present in Western Norway as early as 1969. Scand. J. Infect. Dis.22(2), 241–242 (1990).
  • Vassiliadis P, Kanellakis A, Papadakis J. Sulphadiazine-resistant group A meningococci isolated during the 1968 meningitis epidemic in Greece. J. Hyg. (Lond.)67, 279–287 (1969).
  • Mihalcu F, Iacob A, Levenet I. Epidemiology of meningococcal meningitis in Romania 1971–1991. Roum. Arch. Microbiol. Immunol.52(1), 57–65 (1993).
  • Ballarda D, Ventura G, Tumbarello M, Cauda R, Toti L, Ortona L. Meningococcal meningitis in Italy: 1887–1986. Eur. J. Epidemiol.7(4), 431–433 (1991).
  • Jonsdottir KE. Meningococcal disease in Iceland, 1975–1984. Int. J. Gen Mol. Microbiol.52(3), 258 (1986).
  • Bøvre K, Gedde-Dahl TW. Epidemiological patterns of meningococcal disease in Norway 1975–1979. NIPH Ann.3(2), 9–22 (1980).
  • Bøvre K. Meningococcal disease in Norway. Antonie Van Leeuwenhoek52(3), 208–211 (1986).
  • Lystad A, Aasen S. The epidemiology of meningococcal disease in Norway 1975–1991. NIPH Ann.14(2), 57–65 (1991).
  • Fischer M, Perkins B. Neisseria meningitidis serogroup B: emergence of the ET-5 complex. Sem. Pediatr. Infect. Dis.8(1), 50–56 (1997).
  • Stuart JM, Cartwright KA, Jones DM et al. An outbreak of meningococcal disease in Stonehouse: planning and execution of a large-scale survey. Epidemiol. Infect.99(3), 579–589 (1987).
  • Yazdankhah SP, Kriz P, Tzanakaki G et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J. Clin. Microbiol.42(11), 5146–5153 (2004).
  • Carion F, Van Looveren M, Goosens H. New epidemiological features of meningococcal disease in Belgium. Eurosurveillance2(10), 80 (1997).
  • Gray SJ, Trotter CL, Ramsay ME et al. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the meningococcal reference unit. J. Med. Microbiol.55(7), 887–896 (2006).
  • O’Brien S, Smart L. Meninogoccal infection in Scotland, 1995–1997. Eurosurveillance2(10), pii: 19562 (1997).
  • Gryniewicz O, Kolbusz J, Rosinska M, Zielinski A, Stefanoff P. Epidemiology of meningococcal meningitis and changes in the surveillance system in Poland, 1970–2006. Eurosurveillance12(5), E7–E8 (2007).
  • Trotter CL, Fox AJ, Ramsay ME et al. Fatal outcome from meningococcal disease – an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J. Med. Microbiol.51(10), 855–860 (2002).
  • Iversen BG, Aavitsland P. Meningococcal disease in Norway 1992–1995. Epidemiology and fatality. Scand. J. Infect. Dis.28(3), 253–259 (1996).
  • Communicable Disease Surveillance Centre. Clusters of invasive meningococcal infection in schools. Commun. Dis. Rep. CDR Wkly5, 292 (1995).
  • Kaczmarski E. Meningococcal disease in England and Wales: 1995. Commun. Dis. Rep. CDR Rev.7(4), R55–R59 (1997).
  • Ramsay M, Kaczmarski E, Rush M, Mallard R, Farrington P, White J. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun. Dis. Rep. CDR Rev.7(4), R49–R54 (1997).
  • Communicable Disease Surveillance Centre. Meningococcal disease in England and Wales. Outbreak due to Neisseria meningitidis serogroup C2b. Commun. Dis. Rep. CDR Wkly6, 17 (1996).
  • Theodoridou MN, Vasilopoulou VA, Atsali EE et al. Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period. BMC Infect. Dis.7, 101 (2007).
  • Kriz P, Kalmusova J, Musilek M. New clone of Neisseria meningitidis Y causing invasive meningococcal disease in the Czech Republic. Presented at: 15th European Congress of Clinical Microbiology and Infectious Disease. Copenhagen, Denmark, 2–5 April 2005.
  • Kriz P, Musilek M, Vackova Z, Kozakova J. Invasive meningococcal disease caused by serogroup Y in the Czech Republic. Presented at: 11th European Monitoring Group on Meningococci. Ljubljana, Slovenia, 18–20 May 2011.
  • Jones DM, Sutcliffe EM. Group A meningococcal disease in England associated with the Haj. J. Infect.21(1), 21–25 (1990).
  • Denamur E, Pautard JC, Ducroix JP et al. Meningococcal disease due to group A Neisseria meningitidis in contacts of Mecca pilgrims. Lancet2(8569), 1211 (1987).
  • Riou JY, Caugant DA, Selander RK, Poolman JT, Guibourdenche M, Collatz E. Characterization of Neisseria meningitidis serogroup A strains from an outbreak in France by serotype, serosubtype, multilocus enzyme genotype and outer membrane protein pattern. Eur. J. Clin. Microbiol. Infect. Dis.10(5), 405–409 (1991).
  • Handysides S, Spanjaard L, Lévy-Bruhl D et al. Meningococcal infection in pilgrims returning from the Haj: update from Europe and beyond. Eurosurveillance4(17), 149–152 (2000).
  • Aguilera JF, Perrocheau A, Meffre C, Hahne S. Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg. Infect. Dis.8(8), 761–767 (2002).
  • Commission decision of 28 April 2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable disease to the Community network under Decison No. 2119/98/EC of the European Parliament of the Council (2008/246/EC). Official Journal of the European UnionL159, 46–90 (2008).
  • Rouaud P, Perrocheau A, Taha MK et al. Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005. Euro Surveill.11(7), 178–181 (2006).
  • Delisle E, Larrieu S, Simoes J et al. Community outbreak of group B meningococcal disease in southwest France–December 2008 to September 2009. Euro Surveill.15(37), pii: 19665 (2010).
  • Campbell H, Borrow R, Salisbury D, Miller E. Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine27(Suppl. 2), B20–B29 (2009).
  • Martinez AI, Dominguez A, Oviedo M et al. Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain). Vaccine27(25–26), 3496–3498 (2009).
  • Maiden MC, Ibarz-Pavon AB, Urwin R et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J. Infect. Dis.197(5), 737–743 (2008).
  • Luca V, Gessner BD, Luca C et al. Incidence and etiological agents of bacterial meningitis among children <5 years of age in two districts of Romania. Eur. J. Clin. Microbiol. Infect. Dis.23(7), 523–528 (2004).
  • Tsolia MN, Theodoridou M, Tzanakaki G et al. Invasive meningococcal disease in children in Greece: comparison of serogroup A disease with disease caused by other serogroups. Eur. J. Clin. Microbiol. Infect. Dis.25(7), 449–456 (2006).
  • Brehony C, Jolley KA, Maiden MC. Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol. Rev.31(1), 15–26 (2007).
  • Hedberg ST, Törös B, Fredlund H, Olcén P, Mölling P. Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010. Eurosurveillance16(23), pii: 19885 (2011).
  • Fazio C, Neri A, Starnino S, Sofia T, Mastrantonio P, Stefanelli P. Characterization of invasive serogroup Y meningococci in Italy: prevalence of ST-23 Complex/Cluster A3. New Microbiol.31(4), 467–472 (2008).
  • Traore Y, Njanpop-Lafourcade BM, Adjogble KL et al. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002–2005. Clin. Infect. Dis.43(7), 817–822 (2006).
  • Kilic A, Urwin R, Li H, Saracli MA, Stratton CW, Tang YW. Clonal spread of serogroup W135 meningococcal disease in Turkey. J. Clin. Microbiol.44(1), 222–224 (2006).
  • Ceyhan M, Yildirim I, Balmer P et al. A prospective study of etiology of childhood acute bacterial meningitis, Turkey. Emerg. Infect. Dis.14(7), 1089–1096 (2008).
  • Hubert B. Recent changes in meningococcal disease in Europe. Eurosurveillance2(10), 69–71 (1997).
  • Howitz M, Lambertsen L, Simonsen JB, Christensen JJ, Molbak K. Morbidity, mortality and spatial distribution of meningococcal disease, 1974–2007. Epidemiol. Infect.137(11), 1631–1640 (2009).
  • Gottfredsson M, Diggle MA, Lawrie DI et al.Neisseria meningitidis sequence type and risk for death, Iceland. Emerg. Infect. Dis.12(7), 1066–1073 (2006).
  • Carion F. N. meningitidis: is there a meningitidis epidemic? Arch. Public Health55, 323–330 (1997).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.